Home > News > Nanogen Announces $7.7 Million Common Stock Sale
April 7th, 2004
Nanogen Announces $7.7 Million Common Stock Sale
Nanogen, Inc. announced today that it has sold 900,000 shares of its common stock to institutional investors at a price of $8.60 per share, for gross proceeds of approximately $7.7 million. After deducting fees and expenses, Nanogen will receive approximately $7.4 million from the sale, which was conducted pursuant to Nanogen's shelf registration statement filed in January 2004 and increased by 150,000 shares on April 6, 2004. The sale is expected to close today.
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015
Harris & Harris Group Portfolio Company D-Wave Systems Raises an Additional $29 Million (CAD), Closing 2014 Financing at $62 Million (CAD) February 2nd, 2015